Ubs Group Ag Alvotech Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Alvotech stock. As of the latest transaction made, Ubs Group Ag holds 968 shares of ALVO stock, worth $13,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares

968

Previous 2 48300.0%

Holding current value

$13,087

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.76 - $12.99 $10,394 - $12,548	966 Added 48300.0%	968 $11,000
Q1 2024 May 13, 2024	BUY	$11.36 - $17.27 $22 - $34	2 New	2 $0
Q3 2023 Nov 09, 2023	BUY	$8.12 - $10.07 $633 - $785	78 New	78 $0
Q1 2023 May 12, 2023	SELL	$10.01 - $14.03 $2,992 - $4,194	-299 Reduced 11.58%	2,283 $29,000
Q4 2022 Feb 08, 2023	SELL	$5.76 - $10.05 $46,984 - $81,977	-8,157 Reduced 75.96%	2,582 $25,000
Q3 2022 Nov 10, 2022	SELL	$0.73 - $9.55 $2,122 - $27,761	-2,907 Reduced 21.3%	10,739 $73,000
Q2 2022 Aug 10, 2022	BUY	$8.21 - $11.19 $112,033 - $152,698	13,646 New	13,646 $112,000

Others Institutions Holding ALVO

# of Institutions

Shares Held

15.5M

Call Options Held

Put Options Held

View Full List

About Alvotech

Ticker ALVO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 248,650,000
Market Cap $3.36B
Description
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...

More about ALVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account